Publications by authors named "J D Murga"

Background: Six N-acyl derivatives of aminocombretastatin A-4 have been synthesized and evaluated according to their interaction with tubulin and as c-Myc downregulators.

Aims: In search of new promising anti-cancer agents.

Objective: This study is focused on the synthesis and the biological evaluation of N-acyl derivatives of aminocombretastatin A-4 (CA-4).

View Article and Find Full Text PDF

Natural product combretastatin A-4 (CA-4) and its nitrogenated analogue 3'-aminocombretastatin A-4 (AmCA-4) have shown promising antitumor activities. In this study, a range of CA-4 and AmCA-4 derivatives containing amino acid pendants have been synthesized in order to compare their biological actions with those of their parent compounds. Thus, inhibition of cell proliferation on tumor cell lines HT-29, MCF-7 and A-549, as well as on the nontumor cell line HEK-273; in vitro tubulin polymerization; mitotic cell arrest; action on the microtubule cell network and inhibition of VEGF, hTERT, and c-Myc genes have been evaluated.

View Article and Find Full Text PDF

Background: In the last years, many efforts have been made to find colchicine derivatives with reduced toxicity. Additionally, the deregulation of amino acid uptake by cancer cells provides an opportunity to improve anticancer drug effectiveness.

Objective: To design new colchicine derivatives with reduced cytotoxicity and enhanced selectivity by means of introducing aminoacyl groups.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers designed and evaluated seventeen compounds (T.1-T17) as multitarget inhibitors of VEGFR-2 and PD-L1 proteins to address cancer resistance, focusing on structural features like the urea and triazol moieties.
  • The compounds demonstrated antiproliferative activity against various tumor cell lines and were also assessed for their antiangiogenic properties, utilizing techniques such as flow cytometry and ELISA.
  • Notably, compound T.2 showed comparable effects to sorafenib in inhibiting VEGFR-2, while compound T.14 enhanced T.2’s effects on endothelial cell tube formation and also improved inhibition of PD-L1 and c-Myc proteins.
View Article and Find Full Text PDF

Twenty-four derivatives structurally related to honokiol have been synthesized and biologically evaluated. IC values were determined towards the HT-29, MCF-7 and HEK-293 cell lines. Some of these derivatives exhibited comparable or lower IC values than honokiol towards the HT-29 and MCF-7 cell lines or else higher selectivity indexes than the natural product.

View Article and Find Full Text PDF